All In The [EpiPen] Family
David Epstein reports in ProPublica:
If you notice the news and/or aren’t that guy in Plato’s favorite cave, you’ve probably already suffered rage-induced anaphylaxis while reading about the cool 600 percent price increase for EpiPens in recent years. In all the commotion about unaffordable lifesaving injections, however, you probably missed a USA Today story explaining how Mylan Specialty, maker of EpiPen, developed “a near monopoly in school nurses’ offices.” Your three W’s:
USA Today reports that, in 2012, Gayle Manchin became head of the nonprofit National Association of State Boards of Education, and “spearheaded an unprecedented effort” to make schools purchase emergency treatments for allergic reactions. Manchin’s efforts were rewarded, as 11 states created laws to require epinephrine auto-injectors (i.e. EpiPens) in schools, and other states recommended schools get them. And we’re using the strong form of “recommend” here, since the 2013 “EpiPen Law,” as the White House called it, gave funding preference to schools stocking EpiPens. So this is the kind of “recommend” like when you’re playing make-believe and making “vroom” sounds on that Harley parked outside a bar and someone burly walks out and recommends you stop doing that.
Good question. Seems totally reasonable for schools to have emergency treatments handy. Did I mention that the CEO of Mylan is Heather Bresch? Did I mention that her maiden name is Heather Manchin? Did I mention that Gayle Manchin, who helped get schools to purchase EpiPens gave birth to Heather Manchin who runs the company that profits when schools purchase EpiPens? (Oh and Gayle’s husband and Heather’s dad is Sen. Joe Manchin, D-W.Va.) USA Today mentioned all of that stuff. This might take supportive parenting to a heretofore unseen plane of existence.
According to The Guardian, on Wednesday . . .